[Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].

The off-label use of approved pharmaceuticals outside the authorized status is implemented in pharmacotherapy of many diseases, especially for rare diseases and in cases of therapy resistance. The German regulations are presented and analyzed and the relative literature is discussed.